AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
12.22
-0.06 (-0.49%)
At close: Sep 15, 2026, 4:00 PM EDT
12.16
-0.06 (-0.49%)
After-hours: Sep 15, 2026, 7:30 PM EDT
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 62 employees as of December 31, 2025. The number of employees increased by 4 or 7.27% compared to the previous year.
Employees
62
Change (1Y)
4
Growth (1Y)
7.27%
Revenue / Employee
n/a
Profits / Employee
-$1,503,706
Market Cap
601.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 62 | 4 | 7.27% |
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | 33 | 3,300.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Phathom Pharmaceuticals | 371 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| OmniAb | 89 |
| Scribe Therapeutics | 82 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
AGMB News
- 1 day ago - Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study - GlobeNewsWire
- 4 days ago - Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors - GlobeNewsWire
- 12 days ago - Agomab to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - Agomab initiated with an Overweight at Piper Sandler - TheFly
- 27 days ago - Agomab initiated with an Overweight at Cantor Fitzgerald - TheFly
- 27 days ago - Agomab initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - AgomAb Therapeutics NV Earnings release: Q2 2026 - Filings
- 7 weeks ago - Agomab initiated with a Buy at B. Riley - TheFly